Laserfiche WebLink
THE CITY OF Planning Commission <br /> ,,,,komma.,—--- I <br /> Agenda Report <br /> LEASANTON. May 26, 2021 <br /> Item 3 <br /> SUBJECT: PUD-139 and P20-0973 <br /> APPLICANT/ <br /> PROPERTY OWNER: 10x Genomics, Inc. <br /> PURPOSE: Applications for: (1) a Planned Unit Development (PUD) Rezoning <br /> to rezone the subject parcel from C-R (p) (Regional Commercial - <br /> peripheral sites) District to PUD-C-O (Planned Unit Development — <br /> Commercial-Office) District; (2) a PUD Development Plan to <br /> construct up to three new multi-story research and development, <br /> office and laboratory buildings totaling approximately 381,000 <br /> square feet, a parking structure, and related site improvements <br /> over multiple phases; as well as (3) make a finding of General Plan <br /> conformity for a related Development Agreement to vest the <br /> entitlements for the PUD Rezoning and Development Plan. <br /> LOCATION: 1701 Springdale Avenue <br /> GENERAL PLAN: Retail/Highway/Service Commercial, Business and Professional <br /> Offices <br /> ZONING: C-R (p) (Regional Commercial - peripheral sites) <br /> EXHIBITS: Al . Draft Resolution recommending approval of the Draft <br /> Initial Study and Mitigated Negative Declaration (IS/MND) <br /> A2. Draft Resolution recommending approval of the PUD <br /> Rezoning and Development Plan with Draft Conditions of <br /> Approval <br /> A3. Draft Resolution recommending a finding of General Plan <br /> consistency for the Development Agreement <br /> B. Proposed plans, digital color and materials board, and <br /> shade and shadow study prepared by HOK <br /> C. Arborist Report prepared by HortScience/Bartlett Consulting <br /> Dl . Draft Initial Study and Mitigated Negative Declaration <br /> (IS/MND) and Appendices A through K (digital only) <br /> D2. Draft IS/MND Response to Public Comments <br /> E. Draft Development Agreement <br /> F. Minutes of the November 18, 2020 Planning Commission <br /> Work Session (excerpt) <br /> G. Location and Notification Map <br />: <br /> Section 1: Recommends the City Council find the proposed Project's Development Agreement <br /> is consistent with the City's General Plan based on the following: <br /> The Land Use Designation at 1701 Springdale Avenue, Pleasanton is "Retail/Highway/Service <br /> Commercial; Business and Professional Offices", which permits office uses. R&D and laboratory <br /> uses are not separately defined or identified as a land use category in the PMC; however, both <br /> are listed among a broad range of potential uses in the PMC's definition of"Light Industrial." R&D <br /> and laboratory uses are not expressly permitted in the C-R (p) District; thus, the Project would be <br /> consistent with the General Plan Land Use Designation if the subject site is rezoned to PUD. The <br /> proposed 381,000 sq. ft. of building area would result in a floor area ratio (FAR) of 60% for the <br /> subject site. This complies with the 60% maximum FAR permitted for the designated land use. <br /> The proposed Project would further several General Plan Goals, Programs, and Policies, <br />t in diameter or hammer- <br /> head (tee). Standards and options are available through the Livermore-Pleasanton Fire <br /> Department, Fire Prevention Bureau. <br />ter Treatment Measures and Maintenance Agreement." <br /> are in place, subject to the review and approval of the <br /> Chief Building and Safety Official. Such measures shall be maintained until the <br />ould prevent or <br /> 4412928_2 -10- <br /> the Project, which list shall include the following items: <br /> 4412928_2 -8- <br />